[Surgery, radiotherapy or hormonal therapy in the treatment of prostate cancer].
Prostatic cancer (PC) became the first diagnosed cancer in western men and is the second leading cause of cancer death in men. Wide utilisation of serum PSA and free PSA measurements, identifies patients requiring transrectalultrasonography (TRUS) and TRUS guided biopsies. Most prostatic cancers diagnosed today are locally limited and may be treated by radical surgery or radiotherapy. In case of disseminated disease, hormonal manipulations remain the treatment of choice. In that field, many new drugs have been designed to allow medical castration with less complications, especially regarding sexual potency.
Bonnet
P
P
Service d'Urologie, Université de Liège.
Coppens
L
L
Andrianne
R
R
Waltregny
D
D
Keppenne
V
V
Leduc
F
F
Fillet
M
M
Ghammad
S
S
de Leval
J
J
D000328:Adult; D000368:Aged; D000726:Androgen Antagonists / Q000494:pharmacology / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D003657:Decision Making; D007172:Erectile Dysfunction / Q000139:chemically induced; D006801:Humans; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D017430:Prostate-Specific Antigen / Q000032:analysis; D011468:Prostatectomy; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy / Q000601:surgery*
D000726:Androgen Antagonists; D017430:Prostate-Specific Antigen